For Delawareans battling diseases like Alzheimer’s, cancer, dementia, and several other conditions, biomarker testing can be a crucial asset that ensures their care is tailored to their biological needs. Biomarker testing identifies the uniqueness of every patient’s condition, allowing for healthcare professionals to target care more precisely, leading to earlier diagnoses, therapies, and care plans that can save lives.
Under SB 120, biomarker testing will now be more accessible for Delawareans, ensuring that testing will be covered by health insurance plans.